Clonidine Extended-Release Tablets and Dolutegravir 25 mg and 50 mg
Determining the interaction of Clonidine Extended-Release Tablets and Dolutegravir 25 mg and 50 mg and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: clonidine
Brand name: Catapres, Kapvay, Catapres-TTS, Duraclon, Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3
Synonyms: Clonidine, CloNIDine
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Clonidine Extended-Release Tablets-Dolutegravir and lamivudine
- Clonidine Extended-Release Tablets-Dolutegravir and rilpivirine
- Clonidine Extended-Release Tablets-Dolutegravir Sodium
- Clonidine Extended-Release Tablets-Dolutegravir Sodium And Lamivudine
- Clonidine Extended-Release Tablets-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Clonidine Extended-Release Tablets-Dom-Etoposide
- Dolutegravir 25 mg and 50 mg-Clonidine injection
- Dolutegravir 25 mg and 50 mg-Clonidine Oral, Transdermal
- Dolutegravir 25 mg and 50 mg-Clonidine Patch
- Dolutegravir 25 mg and 50 mg-Clonidine Patches
- Dolutegravir 25 mg and 50 mg-Clonidine Tablets
- Dolutegravir 25 mg and 50 mg-Clonidine transdermal